"The U.S. Food and Drug Administration today approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma (NHL). The action was taken under the agency&rsq"...
Zevalin Patient Information including If I Miss a Dose
In this Article
- What is ibritumomab (Zevalin)?
- What are the possible side effects of ibritumomab (Zevalin)?
- What is the most important information I should know about ibritumomab (Zevalin)?
- What should I discuss with my healthcare provider before receiving ibritumomab (Zevalin)?
- How is ibritumomab given (Zevalin)?
- What happens if I miss a dose (Zevalin)?
- What happens if I overdose (Zevalin)?
- What should I avoid while receiving ibritumomab (Zevalin)?
- What other drugs will affect ibritumomab (Zevalin)?
- Where can I get more information?
What happens if I miss a dose (Zevalin)?
Call your doctor for instructions if you miss an appointment for your ibritumomab injection.
What happens if I overdose (Zevalin)?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Overdose symptoms may include weakness, pale skin, and easy bruising or bleeding.
What should I avoid while receiving ibritumomab (Zevalin)?
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
Do not receive a "live" vaccine while using ibritumomab, and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to you. Live vaccines include measles, mumps, rubella (MMR), Bacillus Calmette-Guérin (BCG), oral polio, rotavirus, smallpox, typhoid, yellow fever, varicella (chickenpox), H1N1 influenza, and nasal flu vaccine.
What other drugs will affect ibritumomab (Zevalin)?
Before receiving ibritumomab, tell your doctor if you are using any type of blood thinner or medication used to prevent blood clots, such as:
- abciximab (ReoPro)
- alteplase (Activase);
- anagrelide (Agrylin);
- argatroban (Acova);
- bivalirudin (Angiomax)
- cilostazol (Pletal);
- clopidogrel (Plavix);
- dabigatran (Pradaxa);
- dalteparin (Fragmin);
- dipyridamole (Persantine, Aggrenox);
- enoxaparin (Lovenox)
- eptifibatide (Integrelin);
- fondaparinux (Arixtra);
- lepirudin (Refludan);
- prasugrel (Effient);
- rivaroxaban (Xarelto);
- tenecteplase (TNKase);
- ticlopidine (Ticlid);
- tinzaparin (Innohep);
- tirofiban (Aggrastat);
- urokinase (Abbokinase); or
- warfarin (Coumadin, Jantoven).
This list is not complete and there may be other drugs that can interact with ibritumomab. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
Where can I get more information?
Your doctor or pharmacist can provide more information about ibritumomab.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 4.02. Revision date: 3/21/2012.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Zevalin Information
Zevalin - User Reviews
Zevalin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.